Shaoqiang Cheng
150 Haping Road
Harbin, China
Harbin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
A Lamp2a-linked RNA secreted by ADSCs prevents ENO1-lactylation-glycolysis feedback and cell malignant behavior in triple-negative breast cancer.
Journal: Cell death & disease
Published: June 12, 2025
ZMIZ1 lactylation induces tamoxifen resistance in breast cancer through increasing transcriptional activity of Nanog to impact cell stemness and cholesterol uptake.
Journal: Cell biology and toxicology
Published: January 26, 2025
Novel models based on machine learning to predict the prognosis of metaplastic breast cancer.
Journal: Breast (Edinburgh, Scotland)
Published: August 26, 2024
The tremendous clinical potential of the microbiota in the treatment of breast cancer: the next frontier.
Journal: Journal of cancer research and clinical oncology
Published: May 22, 2023
Predictive value of controlling nutritional status score in postoperative recurrence and metastasis of breast cancer patients with HER2-low expression.
Journal: Frontiers in oncology
Published: December 05, 2022
Correlation analysis between androgen receptor and the clinicopathological features and prognosis of mammary Paget's disease.
Journal: Journal of cancer research and clinical oncology
Published: February 14, 2022
Correlation analysis of lymphocyte-monocyte ratio with pathological complete response and clinical prognosis of neoadjuvant chemotherapy in patients with breast cancer.
Journal: Translational oncology
Published: December 08, 2021
Retraction Note to: Long non-coding RNA SATB2-AS1 inhibits microRNA-155-3p to suppress breast cancer cell growth by promoting breast cancer metastasis suppressor 1-like.
Journal: Cancer cell international
Published: February 15, 2021
Long non-coding RNA SATB2-AS1 inhibits microRNA-155-3p to suppress breast cancer cell growth by promoting breast cancer metastasis suppressor 1-like.
Journal: Cancer cell international
Published: March 16, 2020
FSTL1 enhances chemoresistance and maintains stemness in breast cancer cells via integrin β3/Wnt signaling under miR-137 regulation.
Journal: Cancer biology & therapy
Published: October 19, 2018
HOXD3 Plays a Critical Role in Breast Cancer Stemness and Drug Resistance.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: September 19, 2017
Last Updated: 09/26/2026